AUD 0.03
(-14.29%)
Year | Eps | Eps Growth |
---|---|---|
2024 | -0.01 AUD | 62.9% |
2023 | -0.02 AUD | 52.76% |
2022 | -0.05 AUD | 20.57% |
2021 | -0.07 AUD | -55.16% |
2020 | -0.04 AUD | 0.0% |
2019 | - AUD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.01 AUD | -100.0% |
2024 Q4 | -0.00 AUD | -182.35% |
2024 FY | - AUD | 62.9% |
2024 Q3 | -0.00 AUD | 75.71% |
2024 Q1 | -0.00 AUD | 45.31% |
2023 Q1 | -0.01 AUD | 32.18% |
2023 FY | - AUD | 32.79% |
2023 Q4 | -0.01 AUD | 0.0% |
2023 Q3 | -0.01 AUD | 45.3% |
2023 Q2 | -0.01 AUD | -98.31% |
2022 Q1 | -0.03 AUD | -21.43% |
2022 FY | - AUD | -37.17% |
2022 Q4 | -0.01 AUD | 0.0% |
2022 Q2 | -0.03 AUD | 0.0% |
2022 Q3 | -0.01 AUD | 65.88% |
2021 Q3 | -0.02 AUD | -218.18% |
2021 Q4 | -0.02 AUD | 0.0% |
2021 Q2 | -0.01 AUD | 34.0% |
2021 Q1 | -0.01 AUD | -203.03% |
2021 FY | - AUD | -93.53% |
2020 Q4 | -0.00 AUD | 0.0% |
2020 Q1 | -0.02 AUD | 0.0% |
2020 Q3 | -0.00 AUD | 83.5% |
2020 Q2 | -0.02 AUD | 0.0% |
2020 FY | - AUD | 12.58% |
2019 FY | - AUD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Alcidion Group Limited | -0.01 AUD | -43.75% |
Artrya Limited | -0.18 AUD | 94.889% |
Beamtree Holdings Limited | -0.02 AUD | 49.171% |
Cogstate Limited | 0.05 AUD | 119.492% |
Careteq Limited | -0.01 AUD | 20.0% |
Doctor Care Anywhere Group PLC | -0.05 AUD | 82.101% |
Emyria Limited | -0.03 AUD | 71.16% |
Global Health Limited | -0.02 AUD | 59.292% |
Intelicare Holdings Limited | -0.01 AUD | 8.0% |
ImExHS Limited | -0.10 AUD | 90.8% |
Mach7 Technologies Limited | -0.03 AUD | 72.205% |
MedAdvisor Limited | 0.00 AUD | 807.692% |
Oakridge International Limited | -0.04 AUD | 78.654% |
Opyl Limited | -0.02 AUD | 49.727% |
PainChek Limited | -0.01 AUD | -61.404% |
Pro Medicus Limited | 0.79 AUD | 101.165% |
Resonance Health Limited | 0.00 AUD | 2400.0% |
Singular Health Group Ltd | -0.03 AUD | 70.13% |
Total Brain Limited | -0.15 AUD | 93.867% |